MiNK Therapeutics's total assets for Q2 2025 were $2.48M, a decrease of -41.78% from the previous quarter. INKT total liabilities were $27.67M for the fiscal quarter, a 6.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.